Zeniplatin

This classification denotes a platinum compound with the molecular formula C6H6O4.C5H14N2O2.Pt, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40ZQ0A17IT, chemically known as platinum, (2,2-bis(aminomethyl)-1,3-propanediol-n,n)(1,1-cyclobutanedicarboxylato(2-))-, (sp-4-2)- but more generally known as zeniplatin, which bears US NIH Compound Identifier 60505. European Medicines Agency schedules Zeniplatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00146MIG. The term ZENIPLATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). ZENIPLATIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, ZENIPLATIN remains US FDA's Preferred Term for this commodity. Zeniplatin bears US NLM identifiers UMLS ID C0055849 and NCI Concept Code C1053. Most nations, for tariff and trade purposes, schedule zeniplatin under HS 28439090 and SITC 52432. SMILES: C1CC(C1)(C(=O)[O-])C(=O)[O-].C(C(CN)(CO)CO)N.[Pt+2].